Gynesonics, USA

Women's Health


HBM contact: Dr Chandra Leo

Company status: private

Gynesonics focuses on the incision-less therapy of symptomatic uterine fibroids, the most common benign tumors in women. Gynesonics has developed VizAblate®, a transcervical, ultrasound-guided ablation system which has a CE Mark in the European Union.  

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171